Shares of Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL - Get Free Report) shot up 7.7% on Friday . The company traded as high as $16.02 and last traded at $15.89. 194,152 shares changed hands during mid-day trading, a decline of 50% from the average daily volume of 386,535 shares. The stock had previously closed at $14.75.
Analyst Ratings Changes
ANL has been the subject of a number of recent research reports. JonesTrading started coverage on shares of Adlai Nortye in a research report on Thursday, May 14th. They issued a "buy" rating and a $22.00 target price for the company. Wall Street Zen raised shares of Adlai Nortye from a "hold" rating to a "buy" rating in a research note on Saturday, August 22nd. Cantor Fitzgerald started coverage on shares of Adlai Nortye in a report on Monday, June 22nd. They issued an "overweight" rating for the company. Oppenheimer started coverage on shares of Adlai Nortye in a research note on Thursday, May 28th. They issued an "outperform" rating and a $32.00 target price on the stock. Finally, Weiss Ratings reissued a "sell (e+)" rating on shares of Adlai Nortye in a research note on Tuesday, July 14th. Five investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $24.25.
Check Out Our Latest Stock Report on ANL
Adlai Nortye Price Performance
The company's 50 day simple moving average is $12.45 and its 200 day simple moving average is $11.35. The company has a debt-to-equity ratio of 0.04, a current ratio of 9.55 and a quick ratio of 0.65.
Insiders Place Their Bets
In other Adlai Nortye news, CFO Xiaofeng Ye sold 5,667 shares of the stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $14.25, for a total value of $80,754.75. Following the sale, the chief financial officer owned 147,757 shares of the company's stock, valued at $2,105,537.25. This trade represents a 3.69% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Institutional Trading of Adlai Nortye
Large investors have recently made changes to their positions in the company. ADAR1 Capital Management LLC acquired a new position in Adlai Nortye during the 1st quarter worth approximately $816,000. Affinity Asset Advisors LLC acquired a new stake in shares of Adlai Nortye in the 1st quarter valued at $1,140,000. Boone Capital Management LLC acquired a new stake in shares of Adlai Nortye in the 2nd quarter valued at $2,971,000. Braidwell LP acquired a new position in shares of Adlai Nortye during the second quarter worth $9,145,000. Finally, Seven Fleet Capital Management LP acquired a new position in shares of Adlai Nortye during the second quarter worth $1,302,000. 35.21% of the stock is currently owned by hedge funds and other institutional investors.
About Adlai Nortye
(
Get Free Report)
Adlai Nortye Inc NASDAQ: ANL is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.
Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.
The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Adlai Nortye, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adlai Nortye wasn't on the list.
While Adlai Nortye currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
